Material Event (Form 8-K)

Item 8.01. Other Events

As previously reported in the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2026, Drugs Made In America Acquisition II Corp. (the "Company") announced that, between the completion of its initial public offering on September 26, 2025 and December 31, 2025, the sponsor to the Company made certain improper withdrawals (the "Irregularities") from the Company's working capital account.

As a result of the events reported above, the board of directors of the Company immediately took action to confirm that the Irregularities did not extend to the Company's trust account ("Trust Account"), and as of today, March 6, 2026, the Company is confirming that approximately $507,841,957 is the Trust Account.